Literature DB >> 11898533

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.

R T Schapiro1.   

Abstract

Multiple sclerosis (MS) is a disease with tremendous variability and innumerable symptoms. Among the more common symptoms is spasticity. Despite a lack of full knowledge of the physiology causing this phenomenon, successful treatments have been developed. Many of these have had a recent introduction. Pain and paroxysmal phenomena are surprisingly common in MS, but have not had the recognition their frequency deserves. It is not unusual to hear that they are rare in MS, but surprisingly they are all too common. Their management is changing as newer treatments are developed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11898533     DOI: 10.1007/s11910-001-0034-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  43 in total

1.  Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions.

Authors:  M T de Mello; D L Poyares; S Tufik
Journal:  Spinal Cord       Date:  1999-09       Impact factor: 2.772

2.  Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin.

Authors:  L Bianchi; F Monaldi; S Paolucci; C Iani; F Lacquaniti
Journal:  Funct Neurol       Date:  1999 Apr-Jun

3.  Paroxysmal superior rectus and levator palpebrae spasm: a unique presentation of multiple sclerosis.

Authors:  E Ezra; G T Plant
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

4.  Paroxysmal convergence spasm in multiple sclerosis.

Authors:  T Postert; U McMonagle; T Büttner; D Pöhlau; S Meves; H Przuntek
Journal:  Acta Neurol Scand       Date:  1996-07       Impact factor: 3.209

Review 5.  Cannabis and cannabinoids: pharmacology and rationale for clinical use.

Authors:  R G Pertwee
Journal:  Forsch Komplementarmed       Date:  1999-10

6.  Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

Authors:  C Brodeur; J Montplaisir; R Godbout; R Marinier
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

7.  Amantadine is beneficial in restless legs syndrome.

Authors:  V G Evidente; C H Adler; J N Caviness; J G Hentz; K Gwinn-Hardy
Journal:  Mov Disord       Date:  2000-03       Impact factor: 10.338

8.  Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis.

Authors:  G Broggi; P Ferroli; A Franzini; D Servello; I Dones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-01       Impact factor: 10.154

Review 9.  Neuropathophysiology of movement disorders in cerebral palsy.

Authors:  F M Filloux
Journal:  J Child Neurol       Date:  1996-11       Impact factor: 1.987

10.  Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study.

Authors:  D Urgosik; J Vymazal; V Vladyka; R Liscák
Journal:  Stereotact Funct Neurosurg       Date:  1998-10       Impact factor: 1.875

View more
  3 in total

Review 1.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 2.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 3.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.